Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease (NCT06872905)
🩺 Plain-English Summary (8th-Grade Level)
The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).
Who can join: Review the eligibility criteria below.
Location: University of California — Fresno, California
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (26 Sites)
Showing the first 25 of 26 sites.
- University of California — Fresno, California
- University of South Florida — Tampa, Florida
- Mayo Clinic Rochester — Rochester, Minnesota
- Cooper University Hospital — Camden, New Jersey
- Rutgers — New Brunswick, New Jersey
- Research Foundation SUNY Buffalo — Buffalo, New York
- Mount Sinai Medical Center — New York, New York
- Research Foundation at SUNY Syracuse — Syracuse, New York
- Atrium Health Sanger Heart & Vascular Institute — Charlotte, North Carolina
- Ohio State University Medical Center — Columbus, Ohio
- Geisinger Medical Center — Danville, Pennsylvania
- University Of Pennsylvania — Philadelphia, Pennsylvania
- Sanford Clinical Vascular Associates — Sioux Falls, South Dakota
- Wellmont Holston Valley Medical Center — Kingsport, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee
- The University of Texas Austin — Austin, Texas
- University of Virginia — Charlottesville, Virginia
- Carilion Clinic — Roanoke, Virginia
- Marshfield Hospital — Marshfield, Wisconsin
- Marshfield Medical Center - Marshfield — Marshfield, Wisconsin
- Azienda Ospedaliero-Universitaria di Padova — Padova,
- Ospedale di Circolo e Fondazione Macchi — Varese,
- Amsterdam UMC Research BV — Amsterdam,
- Franciscus — Rotterdam,
- Hospital General Universitario de Alicante — Alicante,
📞 Contact the Study Coordinator
Phone: (480) 536-5820
Email: jcamoria@wlgore.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortoiliac Occlusive Disease
Explore by condition: All Aortoiliac Occlusive Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.